Delivery Order SPE2DB20D2104-SPE2DB25FMHHE
Award Date
2/4/25
Potential Completion Date
2/5/25
Potential Value
$18K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract award has a ceiling value of $2,076.00 and covers the delivery of Glimepiride 4 mg tablets. The contract is a firm fixed-price delivery order with an ultimate completion date of January 27, 2025. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $22,462.49, is for the supply of Glimepiride 4 mg tablets in 100-count bottles. The contract has a firm-fixed-price structure and a completion date of September 24, 2024. This order is placed under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,889.98, is for the delivery of 4,566,736,019 units of the medication Glimepiride 4 mg tablet in bottles of 100. The contract is a firm fixed-price delivery order, with an ultimate completion date of December 17, 2024. This award is part of AmerisourceBergen's...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,025.72 contract is for the delivery of Glimepiride 4 mg tablets to support federal healthcare programs. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $8,550.43 to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of 4,565,455,148 units of the pharmaceutical drug Glimepiride 4 mg tablets in 100-count bottles. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The order, valued at $2,388.72, is a firm fixed-price contract with an ultimate completion date of August 2, 2024. Amerisourcebergen is providing these prescription medications without any set-aside designation. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999, held...
This is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,093.20, is for the provision of Glimepiride 4 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for supplying a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,529.84 fixed-price delivery order is for the supply of 4 mg glimepiride tablets, a medication used to treat type 2 diabetes. The contract has an ultimate completion date of February 21, 2025 and was awarded on February 20, 2025. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Glimepiride 4 mg tablets. The contract is a firm-fixed-price delivery order with a ceiling value of $4,080.24 and has an ultimate completion date of September 5, 2024. The contract is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract with the DLA Troop Support Medical valued at $999,999,999, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,604.97 firm fixed-price contract is for the delivery of 4,566,149,248 units of the generic medication glimepiride 2 mg tablets. The contract has an ultimate completion date of October 21, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as...